Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Richert B, Theunis A, Norrenberg S, Andre J
For employers, these developments could lead to shifts in formulary decisions and cost-sharing strategies
Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants
The drug levels of medications with narrow therapeutic windows (ie Warfarin) should be monitored closely while on compounded GLP-1s
The STEP trials are testing semaglutide at the higher dose of 2.4 mg/week (as compared to 1.0 mg/week for the original diabetes indication), specifically for promoting weight loss, regardless of the presence of type 2 diabetes
US$ 26.05
US$ 25.35
US$ 27.74
US$ 21.90
US$ 24.94
US$ 29.15
